Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02944578 · ClinicalTrials.gov registry record · Phase 2
Topical Curcumin for Precancer Cervical Lesions
A Phase 2 study, sponsored by Lisa Flowers.
- Terminated
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT02944578 is a Phase 2 study that was terminated before completion, run by Lisa Flowers. The registered enrollment target is 7 participants.
The verdict
NCT02944578, a Phase 2 study, was terminated before completion, sponsored by Lisa Flowers.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to see if curcumin can reverse a cervical precancerous state by looking at people who have the condition and intervening with a study drug or placebo (an inactive drug), prior to planned therapeutic loop electrosurgical excision procedure (LEEP) which is a treatment procedure for removing cervical cancer. 40 women with high grade squamous intraepithelial lesion (HSIL) of the cervix will be enrolled to either insert 2000 mg capsule of curcumin or a placebo in their vagina once a week for 12 weeks. After a 4 week long washout period the participants will then undergo removal of the precancerous cells as recommended standard of care. Participants will have regular monthly visits for the duration of the study.
Interventions
- DRUG Placebo
- DRUG Curcumin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-11-20 |
| Est. Completion | 2018-10-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02944578
The ClinicalTrials.gov registry entry for NCT02944578 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lisa Flowers, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02944578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02944578 about?
NCT02944578 is a clinical study titled "Topical Curcumin for Precancer Cervical Lesions". The purpose of this study is to see if curcumin can reverse a cervical precancerous state by looking at people who have the condition and intervening with a study drug or placebo (an inactive drug), prior to planned therapeutic loop electrosurgical excision procedure (LEEP) which is a treatment proc...
What is the current status of trial NCT02944578?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2017-11-20. Estimated completion is 2018-10-30.
What interventions are being tested in trial NCT02944578?
The interventions under investigation include: Placebo (DRUG), Curcumin (DRUG).
Who is sponsoring clinical trial NCT02944578?
This trial is sponsored by Lisa Flowers, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.